Cough Drug Abuse By Teens Drops, But Persists Among Younger Children
This article was originally published in The Tan Sheet
You may also be interested in...
FDA Panel Says Leave DXM Unscheduled For Now, Urges Congressional Action
Dextromethorphan likely will escape scheduling as a controlled substance in the near term, but manufacturers and lawmakers should push efforts to curb abuse to keep the cough suppressant available OTC in the long run
DXM Panel Proposes Augmenting, Improving Education To Curb Abuse
Members of an FDA panel tipped their hats to the Consumer Healthcare Product Association's efforts to reduce dextromethorphan abuse, but floated enhancements to the program
Extent Of DXM Abuse May Not Support Scheduling
Dextromethorphan abuse is increasing slightly, but the problem is not widespread, according to FDA. One expert notes the extent might not justify scheduling the cough suppressant as a controlled substance